# Cormorant Capital: portfolio, investments and team

> Cormorant Capital is a vc firm based in United States. 26 investments on record, 1 in the last 12 months, latest Jul 2026.

Source: https://millionrounds.com/fund/cormorant-capital (Millionrounds; every figure on the page links to its filing or article)

United States · [Investor](https://millionrounds.com/investors)

# Cormorant Capital

Last cheque observed Jul 2026; 26 cheques on record.

Email

Deploying now New fund $5.5M, Mar 2011 VC firm

Seed Series A Series B Genetics Pharmaceutical Real Estate

Follow Cormorant Capital and see its new cheques in your feed. [Start following](https://millionrounds.com/login?join=1&why=follow&next=%2Ffund%2Fcormorant-capital)

Deploying now

**100%** of best year **1** **cheques in 12 months**, 26 on record

Since the last cheque **116** days **00** hrs **00** min **00** sec

Median round **$69M** Rounds led **0 of 26** Mostly in **United States, 85%**

Pitch Cormorant Capital

## Cormorant Capital highlights

- 01 1 cheques in the last 12 months
- 02 Mostly Series C and Series B: 85% of its rounds

## What they do

- **Type:** VC firm (from a list, unverified)
- **Cheque size:** Not stated
- **Stages:** Seed Series A Series B Growth
- **Sectors:** Genetics Pharmaceutical Real Estate
- **Based in:** New York, United States
- **Cold pitches:** Not stated

## The record

Every round we can evidence, newest first **26 appearances**

- **2026** 1 round
- **Jul** **[FORE Biotherapeutics](https://millionrounds.com/company/fore-biotherapeutics)** Series D · US · Ventureburn **$67M** With 15 others
- **2019** 3 rounds
- **Jul** **[Revolution Medicines](https://millionrounds.com/company/revolution-medicines)** Series C · US · FinSMEs **$100M** With 9 others
- **Apr** **[Sasuma Pharmaceuticals](https://millionrounds.com/company/sasuma-pharmaceuticals)** US · Biospace **$62M** With 9 others
- **Jan** **[BridgeBio](https://millionrounds.com/company/bridgebio)** US · FinSMEs **$299M** With 6 others
- **2018** 13 rounds
- **Dec** **[Akero Therapeutics](https://millionrounds.com/company/akero-therapeutics)** Series B · US · FinSMEs **$70M** With 9 others
- **Nov** **[Harpoon](https://millionrounds.com/company/harpoon)** Series C · US · FinSMEs **$70M** With 7 others
- **Oct** **[Stoke Therapeutics](https://millionrounds.com/company/stoke-therapeutics)** Series B · US · FinSMEs **$90M** With 7 others
- **Oct** **[TP Therapeutics](https://millionrounds.com/company/tp-therapeutics)** US · FinSMEs **$80M** With 6 others
- **Sept** **[Atreca](https://millionrounds.com/company/atreca)** Series C · US · FinSMEs **$125M** With 7 others
- **Aug** **[Renovia](https://millionrounds.com/company/renovia)** US · FinSMEs **$42M** With 4 others
- **Aug** **[Orchard Therapeutics](https://millionrounds.com/company/orchard-therapeutics)** Series C · GB · FinSMEs **$150M** With 14 others
- **Jun** **[Cibus](https://millionrounds.com/company/cibus)** Series C · US · FinSMEs **$70M** With 2 others
- **Jun** **[Precision](https://millionrounds.com/company/precision)** Series B · US · FinSMEs **$110M** With 18 others
- **Apr** **[Corvidia](https://millionrounds.com/company/corvidia)** Series B · US · FinSMEs **$60M** With 8 others
- **Apr** **[Constellation](https://millionrounds.com/company/constellation)** US · FinSMEs **$100M** With 12 others
- **Apr** **[Edios](https://millionrounds.com/company/edios)** Series B · US · FinSMEs **$64M** With 6 others
- **Apr** **[CMAB](https://millionrounds.com/company/cmab)** Series B · CN · FinSMEs **$34M** With 3 others
- **2017** 9 rounds
- **Nov** **[Tricida](https://millionrounds.com/company/tricida)** Series D · US · FinSMEs **$58M** With 7 others
- **Sept** **[Autolous](https://millionrounds.com/company/autolous)** Series C · GB · FinSMEs **$80M** With 4 others
- **Sept** **[BridgeBio](https://millionrounds.com/company/bridgebio)** US · FinSMEs **$135M** With 5 others
- **Sept** **[Replimune](https://millionrounds.com/company/replimune)** Series B · US · FinSMEs **$55M** With 6 others
- **Jul** **[Axonics](https://millionrounds.com/company/axonics)** Series C · US · FinSMEs **$21M** With 2 others
- **Jun** **[Zai Lab](https://millionrounds.com/company/zai-lab)** Series C · CN · FinSMEs **$30M** With 2 others
- **Mar** **[Solid Biosciences](https://millionrounds.com/company/solid-biosciences)** Series C · US · FinSMEs **$50M** With 6 others
- **Mar** **[908 Devices](https://millionrounds.com/company/908-devices)** Growth · US · FinSMEs **$20M** With 6 others
- **Jan** **[Scholar Rock](https://millionrounds.com/company/scholar-rock)** Series C · US · FinSMEs **$47M** With 7 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

## The team

Named by the firm itself, on a filing, its Form ADV or its company registration **2 named**

AM **Alex Mayrus** Managing Member of General Partner i Filing they signed

RA **Richard A Mayrus** Managing Member of General Partner i Filing they signed

We also hold **2** people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

New fund on file

**$5.5M**

raised in Mar 2011

From its SEC filing, not a journalist: a firm that has just raised has money to deploy.

## The cheque

Seed Series A Series B

Median round joined **$69M** the round, not its cheque

Led 0 of 26 rounds **0%**

- **Sole investor:** Never alone
- **Last cheque:** Jul 2026

Rounds by stage said on their site

- Series C *10*
- Series B said *7*
- Series D *2*
- Growth said *1*
- Seed said *-*
- Series A said *-*

Cheques by month Led Joined

Nov 2023 Oct 2026

Often in the room with

- [Fidelity](https://millionrounds.com/fund/fidelity) 4
- [OrbiMed](https://millionrounds.com/fund/orbimed) 4
- [Wellington Management](https://millionrounds.com/fund/wellington-management) 4
- [Boxer Capital](https://millionrounds.com/fund/boxer-capital) 3
- [Casdin Capital](https://millionrounds.com/fund/casdin-capital) 3
- [Perceptive Ventures](https://millionrounds.com/fund/perceptive-ventures) 3

**Pitching Cormorant Capital?** Put them on your fundraising board with this record on the card, and follow them to hear when they write a new cheque.

Add to your CRM *→*

## Who they invest alongside

The investors most often in the same rounds as Cormorant Capital. A count of rooms they were both in, not a relationship either has claimed.

[**Fidelity** VC firm **4** rounds together](https://millionrounds.com/fund/fidelity)[**OrbiMed** Private equity **4** rounds together](https://millionrounds.com/fund/orbimed)[**Wellington Management** VC firm **4** rounds together](https://millionrounds.com/fund/wellington-management)[**Boxer Capital** VC firm **3** rounds together](https://millionrounds.com/fund/boxer-capital)[**Casdin Capital** VC firm **3** rounds together](https://millionrounds.com/fund/casdin-capital)[**Perceptive Ventures** VC firm **3** rounds together](https://millionrounds.com/fund/perceptive-ventures)[**Redmile Group** VC firm **3** rounds together](https://millionrounds.com/fund/redmile-group)[**SR One** Corporate VC **3** rounds together](https://millionrounds.com/fund/sr-one)[**Venrock** VC firm **3** rounds together](https://millionrounds.com/fund/venrock)[**AIG** Corporate VC **2** rounds together](https://millionrounds.com/fund/aig)[**Alexandria Real Estate Equities** VC firm **2** rounds together](https://millionrounds.com/fund/alexandria)[**Apple Tree Partners** VC firm **2** rounds together](https://millionrounds.com/fund/apple-tree-partners)

## Recently backed

The latest companies Cormorant Capital put money into.

[**FORE Biotherapeutics** $67M · Jul 2026](https://millionrounds.com/company/fore-biotherapeutics)[**Revolution Medicines** $100M · Jul 2019](https://millionrounds.com/company/revolution-medicines)[**BridgeBio** $299M · Jan 2019](https://millionrounds.com/company/bridgebio)[**Akero Therapeutics** $70M · Dec 2018](https://millionrounds.com/company/akero-therapeutics)[**Harpoon** $70M · Nov 2018](https://millionrounds.com/company/harpoon)[**Stoke Therapeutics** $90M · Oct 2018](https://millionrounds.com/company/stoke-therapeutics)

## Quick answers about Cormorant Capital

### What does Cormorant Capital invest in?

Cormorant Capital invests most often at Series C and Series B (85% of the rounds on record), in sectors such as Genetics, Pharmaceutical and Real Estate.

### How active is Cormorant Capital?

26 investments on record, 1 of them in the last 12 months. The most recent was in Jul 2026.

### What has Cormorant Capital invested in recently?

Its most recent investments on record: FORE Biotherapeutics (Series D, Jul 2026), Revolution Medicines (Series C, Jul 2019) and Sasuma Pharmaceuticals (Undisclosed round, Apr 2019).

### How big are Cormorant Capital's cheques?

The median round it joins is $69M.

### Does Cormorant Capital lead rounds?

Rarely, if at all: none of its 26 investments on record names it as the lead.

### Where does Cormorant Capital invest?

Most of the companies it backs are in the United States (85%), the United Kingdom (8%) and China (8%).

### Is Cormorant Capital investing now?

Yes: it is actively investing, with 1 investments in the last 12 months.

### Who does Cormorant Capital invest alongside?

Most often Fidelity (4 rounds together), OrbiMed (4 rounds together) and Wellington Management (4 rounds together).

## Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. [How we count](https://millionrounds.com/methodology) · [Report a correction](https://millionrounds.com/corrections?slug=cormorant-capital) · [Is this your firm? Claim it](https://millionrounds.com/claim?org=cormorant-capital)